Xylocaine + Epinephrine — Class II drug recall D-1053-2022
Terminated recall by Mckesson Medical-Surgical Inc. Corporate Office, reported 2022-06-15, distributed nationwide. cGMP deviations: Temperature abuse
| Recall number | D-1053-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA, United States |
| Recall initiated | 2022-04-13 |
| Classified | 2022-06-09 |
| Reported by FDA | 2022-06-15 |
| Terminated | 2023-11-30 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp, temperature control |
| NDC | 63323-0481, 63323-0481-01, 63323-0481-57, 63323-0482, 63323-0482-01, 63323-0482-03, 63323-0482-05, 63323-0482-17, 63323-0482-27, 63323-0482-57, 63323-0483, 63323-0483-01, 63323-0483-03, 63323-0483-27, 63323-0483-57, 63323-0484, 63323-0484-57, 63323-0485, 63323-0485-01, 63323-0485-03, 63323-0485-27, 63323-0485-57, 63323-0486, 63323-0486-01, 63323-0486-02 and 42 more |
Product
Xylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDC 63323-483-27
Reason for recall
cGMP deviations: Temperature abuse
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1053-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.